Efficacy of imatinib mesylate-based front-line therapy in pediatric chronic myelogenous leukemia

PURPOSE: Despite the established role of imatinib (IM) in chronic myelogenous leukemia (CML) in adults, there are few reports on its efficacy in children. In this study, we compared the outcomes of children with CML before and after the advent of IM-based treatment. METHODS: The study cohort consist...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Oh, Hyun Jin, Cho, Mun Sung, Lee, Jae Wook, Jang, Pil-Sang, Chung, Nack-Gyun, Cho, Bin, Kim, Hack-Ki
Format: Artigo
Idioma:Inglês
Publicat: The Korean Pediatric Society 2013
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3764259/
https://ncbi.nlm.nih.gov/pubmed/24019845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3345/kjp.2013.56.8.343
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars